203 related articles for article (PubMed ID: 29195915)
1. Development and in-vitro characterization of nanoemulsions loaded with paclitaxel/γ-tocotrienol lipid conjugates.
Abu-Fayyad A; Kamal MM; Carroll JL; Dragoi AM; Cody R; Cardelli J; Nazzal S
Int J Pharm; 2018 Jan; 536(1):146-157. PubMed ID: 29195915
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of paclitaxel nanoemulsion for cancer therapy.
Shakhwar S; Darwish R; Kamal MM; Nazzal S; Pallerla S; Abu Fayyad A
Pharm Dev Technol; 2020 Apr; 25(4):510-516. PubMed ID: 31858867
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and in-vitro antitumor activity of the polyethylene glycol (350 and 1000) succinate derivatives of the tocopherol and tocotrienol isomers of Vitamin E.
Abu-Fayyad A; Nazzal S
Int J Pharm; 2017 Mar; 519(1-2):145-156. PubMed ID: 28093324
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine-vitamin E conjugates: Synthesis, characterization, entrapment into nanoemulsions, and in-vitro deamination and antitumor activity.
Abu-Fayyad A; Nazzal S
Int J Pharm; 2017 Aug; 528(1-2):463-470. PubMed ID: 28627455
[TBL] [Abstract][Full Text] [Related]
5. PEGylated γ-tocotrienol isomer of vitamin E: Synthesis, characterization, in vitro cytotoxicity, and oral bioavailability.
Abu-Fayyad A; Behery F; Sallam AA; Alqahtani S; Ebrahim H; El Sayed KA; Kaddoumi A; Sylvester PW; Carroll JL; Cardelli JA; Nazzal S
Eur J Pharm Biopharm; 2015 Oct; 96():185-95. PubMed ID: 26235392
[TBL] [Abstract][Full Text] [Related]
6. An optimized two-vial formulation lipid nanoemulsion of paclitaxel for targeted delivery to tumor.
Chen L; Chen B; Deng L; Gao B; Zhang Y; Wu C; Yu N; Zhou Q; Yao J; Chen J
Int J Pharm; 2017 Dec; 534(1-2):308-315. PubMed ID: 28986321
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, physiochemical characterization, and in vitro antitumor activity of the amide and pH cleavable hydrazone conjugates of γ-tocotrienol isomer of vitamin E with methoxy-poly(ethylene) glycol.
Abu-Fayyad A; Nazzal S
Int J Pharm; 2017 Aug; 529(1-2):75-86. PubMed ID: 28627454
[TBL] [Abstract][Full Text] [Related]
8. Effect of PEG surface conformation on anticancer activity and blood circulation of nanoemulsions loaded with tocotrienol-rich fraction of palm oil.
Alayoubi A; Alqahtani S; Kaddoumi A; Nazzal S
AAPS J; 2013 Oct; 15(4):1168-79. PubMed ID: 23990503
[TBL] [Abstract][Full Text] [Related]
9. Concurrent delivery of tocotrienols and simvastatin by lipid nanoemulsions potentiates their antitumor activity against human mammary adenocarcenoma cells.
Alayoubi AY; Anderson JF; Satyanarayanajois SD; Sylvester PW; Nazzal S
Eur J Pharm Sci; 2013 Feb; 48(3):385-92. PubMed ID: 23262057
[TBL] [Abstract][Full Text] [Related]
10. Novel paclitaxel formulations solubilized by parenteral nutrition nanoemulsions for application against glioma cell lines.
Najlah M; Kadam A; Wan KW; Ahmed W; Taylor KM; Elhissi AM
Int J Pharm; 2016 Jun; 506(1-2):102-9. PubMed ID: 27107899
[TBL] [Abstract][Full Text] [Related]
11. Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel.
Lu J; Huang Y; Zhao W; Chen Y; Li J; Gao X; Venkataramanan R; Li S
Mol Pharm; 2013 Aug; 10(8):2880-90. PubMed ID: 23768151
[TBL] [Abstract][Full Text] [Related]
12. Vitamin E-rich Nanoemulsion Enhances the Antitumor Efficacy of Low-Dose Paclitaxel by Driving Th1 Immune Response.
Ye J; Dong W; Yang Y; Hao H; Liao H; Wang B; Han X; Jin Y; Xia X; Liu Y
Pharm Res; 2017 Jun; 34(6):1244-1254. PubMed ID: 28326458
[TBL] [Abstract][Full Text] [Related]
13. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
[TBL] [Abstract][Full Text] [Related]
15. Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization.
Dong X; Mattingly CA; Tseng M; Cho M; Adams VR; Mumper RJ
Eur J Pharm Biopharm; 2009 May; 72(1):9-17. PubMed ID: 19111929
[TBL] [Abstract][Full Text] [Related]
16. Extraction of Vitamin E Isomers from Palm Oil: Methodology, Characterization, and
Abu-Fayyad A; Nazzal S
J Am Oil Chem Soc; 2017 Sep; 94(9):1209-1217. PubMed ID: 33518766
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of tocopherol-rich argan oil-based nanoemulsions as vehicles possessing anticancer activity.
Jordan M; Nayel A; Brownlow B; Elbayoumi T
J Biomed Nanotechnol; 2012 Dec; 8(6):944-56. PubMed ID: 23030003
[TBL] [Abstract][Full Text] [Related]
18. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
[TBL] [Abstract][Full Text] [Related]
19. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles.
Pan J; Feng SS
Biomaterials; 2008 Jun; 29(17):2663-72. PubMed ID: 18396333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
